GlassScriptPhysician profile
Anil G Verma
NPI 1821094665
$5,153.88
in general payments reported to CMS, 2019-2025
37 companies · $793 in 2025
The $793 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,258 · 2020: $198 · 2021: $278 · 2022: $869 · 2023: $943 · 2024: $815 · 2025: $793.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,550.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $617.06 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $424.39 | 2019-2024 | Xarelto |
| Medtronic, INC. | $353.54 | 2021-2025 | Micra |
| Abbott Laboratories | $340.10 | 2019-2025 | Aveir, Confirm Rx, Eterna |
| Merck Sharp & Dohme LLC | $279.40 | 2023-2025 | Verquvo, Belsomra, Capvaxive |
| Boston Scientific Corporation | $240.91 | 2019-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Amgen INC. | $239.13 | 2019-2025 | Repatha, Repatha |
| Biosense Webster, INC. | $238.09 | 2023 | Carto 3 |
| Abiomed | $222.02 | 2019-2025 | Impella |
| Cvrx, INC. | $203.88 | 2023-2025 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $196.78 | 2022-2025 | Camzyos, Eliquis |
| W. L. Gore & Associates, INC. | $186.35 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $183.50 | 2019-2025 | Lifevest |
| Biotronik INC. | $167.19 | 2019 | |
| Pfizer INC. | $162.40 | 2019-2025 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anil Verma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.